anonymous
Guest
anonymous
Guest
Lots of questions / confusion about equity (stock price) here. I’ll put that to rest. I was one of the first posters here and bailed out on the interview after the manager tried to “leach” information from me... I also shorted the stock way back in January (and posted that I was doing that on this board).
You can almost always short biotech companies to $0 (or VERY close to it) as most of them are essentially worthless (check out Aralez, Amarin, etc)
Anyway, I am still short ESPR and will remain short until the $11 range (as I posted in January).
You can almost always short biotech companies to $0 (or VERY close to it) as most of them are essentially worthless (check out Aralez, Amarin, etc)
Anyway, I am still short ESPR and will remain short until the $11 range (as I posted in January).